BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 4674679)

  • 21. [Inhibitory effect of poriatin on murine leukemia 1210 cells].
    Xu J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1988 Feb; 10(1):45-9. PubMed ID: 2968177
    [No Abstract]   [Full Text] [Related]  

  • 22. Antitumor activity of a folate-cleaving enzyme, carboxypeptidase G 1 .
    Chabner BA; Chello PL; Bertino JR
    Cancer Res; 1972 Oct; 32(10):2114-9. PubMed ID: 5080761
    [No Abstract]   [Full Text] [Related]  

  • 23. [Characteristics of the inhibition of DNA synthesis by deoxyadenosine in tumor cells].
    Vornovitskaia GI; Ol'shanetskaia AD; Novikova MA; Karelina LP; Morozova NS
    Biokhimiia; 1972; 37(5):940-7. PubMed ID: 4344203
    [No Abstract]   [Full Text] [Related]  

  • 24. Biochemical mode of cytotoxic action of neplanocin A in L1210 leukemic cells.
    Inaba M; Nagashima K; Tsukagoshi S; Sakurai Y
    Cancer Res; 1986 Mar; 46(3):1063-7. PubMed ID: 3943084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antitumor activity of novel octalactin A analogs in murine leukemia cells in vitro.
    Perchellet JP; Perchellet EM; Newell SW; Freeman JA; Ladesich JB; Jeong Y; Sato N; Buszek K
    Anticancer Res; 1998; 18(1A):97-106. PubMed ID: 9568062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of dose interval on the survival of L1210 leukemic mice treated with DNA synthesis inhibitors.
    Neil GL; Homan ER
    Cancer Res; 1973 Apr; 33(4):895-901. PubMed ID: 4696483
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of nitrogen mustard and cyclophosphamide upon the synthesis of DNA in vivo and in cell-free preparations.
    Wheeler GP; Alexander JA
    Cancer Res; 1969 Jan; 29(1):98-109. PubMed ID: 5812632
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparative effects of the antitumor agents 5-(Dimethyltriazeno)-imidazole-4-carboxamide and 1,3-bis(2-chloroethyl)-1-nitrosourea on cell cycle of L1210 leukemia cells in vivo.
    Shirakawa S; Frei E
    Cancer Res; 1970 Aug; 30(8):2173-90. PubMed ID: 5459764
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparative studies of fluorinated pyrimidines with various cell lines.
    Umeda M; Heidelberger C
    Cancer Res; 1968 Dec; 28(12):2529-38. PubMed ID: 4302536
    [No Abstract]   [Full Text] [Related]  

  • 30. Antitumor activity and mode of action of 2-thio-6-azauridine (NSC-146268) on L1210 leukemia.
    Li LH; Neil GL; Moxley TE; Olin EJ
    Cancer Chemother Rep; 1974; 58(3):345-52. PubMed ID: 4858297
    [No Abstract]   [Full Text] [Related]  

  • 31. Changes in DNA and RNA synthesis and associated enzyme activities after the stimulation of serum-depleted BHK21-C13 cells by the addition of serum.
    Howard DK; Hay J; Melvin WT; Durham JP
    Exp Cell Res; 1974 May; 86(1):31-42. PubMed ID: 4545459
    [No Abstract]   [Full Text] [Related]  

  • 32. Kinetic behavior versus response to chemotherapy.
    Skipper HE
    Natl Cancer Inst Monogr; 1971 Dec; 34():2-14. PubMed ID: 4946581
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of acronycine on nucleic acid synthesis and population growth in mammalian tumor cell cultures.
    Gout PW; Dunn BP; Beer CT
    J Cell Physiol; 1971 Aug; 78(1):127-38. PubMed ID: 5286389
    [No Abstract]   [Full Text] [Related]  

  • 34. Ribonucleotide reductase and DNA synthesis in Ehrlich ascites tumor cells.
    Cory JG; Whitford TW
    Cancer Res; 1972 Jun; 32(6):1301-6. PubMed ID: 5030829
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of 4,4'-diacetyldiphenylurea-bis-(guanylhydrazone) on the incorporation of precursors into nucleic acid and protein of leukemia L1210.
    Soucek J; Ehrke MJ; Mihich E
    Cancer Res; 1970 Aug; 30(8):2187-94. PubMed ID: 5459766
    [No Abstract]   [Full Text] [Related]  

  • 36. Metabolic effects of cyclic 9- -D-arabinofuranosyladenine 3',5'-monophosphate in L1210 cells.
    Hughes RG; Kimball AP
    Cancer Res; 1972 Sep; 32(9):1791-4. PubMed ID: 4345037
    [No Abstract]   [Full Text] [Related]  

  • 37. Use of 5-fluorodeoxycytidine and tetrahydrouridine to exploit high levels of deoxycytidylate deaminase in tumors to achieve DNA- and target-directed therapies.
    Mekras JA; Boothman DA; Perez LM; Greer S
    Cancer Res; 1984 Jun; 44(6):2551-60. PubMed ID: 6539164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of cytosine arabinoside, daunomycin, mithramycin, azacytidine, adriamycin, and camptothecin on mammalian cell cycle traverse.
    Tobey RA
    Cancer Res; 1972 Dec; 32(12):2720-5. PubMed ID: 4118765
    [No Abstract]   [Full Text] [Related]  

  • 39. Intracellular conversions of deoxyribonucleosides by Novikoff rat hepatoma cells and effects of hydroxyurea.
    Plagemann PG; Erbe J
    J Cell Physiol; 1974 Jun; 83(3):321-36. PubMed ID: 4363878
    [No Abstract]   [Full Text] [Related]  

  • 40. A modified screening system to select new cytostatic drugs.
    Kraemer HP; Sedlacek HH
    Behring Inst Mitt; 1984 May; (74):301-28. PubMed ID: 6383326
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.